CDC Clinical Considerations for Mpox in Children and Adolescents in the U.S.

• 2024

  Sign in to bookmark this resource.

  Sign in

---

Access Resources

• Job AidEN

About

This webpage provides guidance on managing mpox in children and teens. It describes how the disease is rare but can spread through close contact. Symptoms include a rash, fever, and swollen lymph nodes. Children with skin conditions or weak immune systems may face severe illness. Treatment options like tecovirimat are available for serious cases, while vaccines like JYNNEOS can be used for prevention after exposure. Safety measures at home and in hospitals are crucial to prevent spreading the virus to others, especially vulnerable groups such as infants or pregnant adolescents.

---

Tags

Hazard: Infectious Disease

Audiences: Nurses; Physicians

Emergency Management Stages: Response; Preparedness (Prevention / Protection)

Keywords: Antiviral Agents; Disease Outbreaks; Pediatrics; Vaccination; Adolescent Health Services; Mpox (monkeypox)

Institutions: Centers for Disease Control and Prevention (CDC)

---

More like this

Biological Incident Annex to the Response and Recovery Federal Interagency Operational Plan 2023 · U.S. Department of Homeland Security Disruptions in Availability of Peritoneal Dialysis and Intravenous Solutions from Baxter International Facility in North Carolina 2024 · Centers for Disease Control and Prevention (CDC) Infection Control Guidance: SARS-CoV-2 2024 · Centers for Disease Control and Prevention (CDC)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---